Macrophage colony-stimulating factor induces vascular endothelial growth factor production in skeletal muscle and promotes tumor angiogenesis

Journal of Immunology

Volumn 174, Issue 12, 2005, Pages 7531-7538

  Okazaki, Tatsuma ^a   Ebihara, Satoru ^a   Takahashi, Hidenori ^a   Asada, Masanori ^a   Kanda, Akio ^a   Sasaki, Hidetada ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; CD11B ANTIGEN; COLONY STIMULATING FACTOR 1; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW SUPPRESSION; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TUMOR GROWTH; TUMOR VASCULARIZATION; WESTERN BLOTTING;

EID: 20444422949     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.12.7531     Document Type: Article

References (42)

1. Ohno, R., S. Miyawaki, K. Hatake, K., Kuriyama, K. Saito, A. Kanamaru, T. Kobayashi, Y. Kodera, K. Nishikawa, S. Matsuda, et al. 1997. Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study. J. Clin. Oncol. 15: 2954-2965.
2. Kawakami, Y., N. Nagai, K. Ohama, K. Zeki, Y. Yoshida, E. Kuroda, and U. Yamashita. 2000. Macrophage-colony stimulating factor inhibits the growth of human ovarian cancer cells in vitro. Eur. J. Cancer 36: 1991-1997.
3. Stanley, E. R., K. L. Berg, D. B. Einstein, P. S. Lee, F. J. Pixley, Y. Wang, and Y. G. Yeung. 1997. Biology and action of colony-stimulating factor-1. Mol. Reprod. Dev. 46: 4-10.
4. Hidaka, T., M. Fujimura, M, Sakai, and S. Saito. 2001. Macrophage colony-stimulating factor prevents febrile neutropenia induced by chemotherapy. Jpn. J. Cancer Res. 92: 1251-1258.
5. Mizutani, K., S. Takeuchi, Y. Ohashi, M. Yakushiji, H. Nishimura, T. Takahashi, T. Maruhashi, K. Ueda, K. Noda, Y. Watanabe, et al. 2003. Clinical usefulness of macrophage colony-stimulating factor for ovarian cancers: long-term prognosis after five years. Oncol. Rep. 10: 127-131.
6. Bock, S. N., R. B. Cameron, P. Kragel, J. J. Mule, and S. A. Rosenberg. 1991. Biological and antitumor effects of recombinant human macrophage colony-stimulating factor in mice. Cancer Res. 51: 2649-2654.
7. Morita, T., K. Ikeda, M. Douzono, M. Yamada, F. Kimura, K. Kawakami, K. Sasaki, K. Motoyoshi, J. Takahara, and S. Irino. 1996. Tumor vaccination with macrophage colony-stimulating factor-producing Lewis lung carcinoma in mice. Blood 88: 955-961.
8. Aharinejad, S., D. Abraham, P. Paulus, H. Abri, M. Hofmann, K. Grossschmidt, R. Schafer, E. R. Stanley, and R. Hofbauer. 2002. Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. Cancer Res. 62: 5317-5324.
9. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1: 27-31.
10. Lyden, D., K. Hattori, S. Dias, C. Costa, P. Blaikie, L. Butros, A. Chadburn, B. Heissig, W. Marks, L. Witte, et al. 2001. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7: 1194-1201.
11. Davidoff, A. M., C. Y. Ng, P. Brown, M. A. Leary, W. W. Spurbeck, J. Zhou, E. Horwitz, E. F. Vanin, and A. W. Nienhuis. 2001. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin. Cancer Res. 7: 2870-2879.
12. Bussolino, F., M. Ziehe, J. M. Wang, D. Alessi, L. Morbidelli, O. Cremona, A. Bosia, P. C. Marchisio, and A. Mantovani. 1991. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J. Clin. Invest. 87: 986-995.
13. Takahashi, T., C. Kalka, H. Masuda, D. Chen, M. Silver, M. Kearney, M. Magner, J. M. Isner, and T. Asahara. 1999. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5: 434-438.
14. Natori, T., M. Sata, M. Washida, Y. Hirata, R. Nagai, and M. Makuuchi. 2002. G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. Biochem. Biophys. Res. Commun. 297: 1058-1061.
15. Ferrara, N., H. P. Gerber, and J. LeCouter. 2003. The biology of VEGF and its receptors. Nat. Med. 9: 669-676.
16. Heissig, B., K. Hattori, S. Dias, M. Friedrich, B. Ferris, N. R. Hackett, R. G. Crystal, P. Besmer, D. Lyden, M. A. Moore, et al. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109: 625-637.
17. Asahara, T., T. Takahashi, H. Masuda, C. Kalka, D. Chen, H. Iwaguro, Y. Inai, M. Silver, and J. M. Isner. 1999. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18: 3964-3972.
18. Ogikubo, Y., M. Norimatsu, K. Noda, J. Takahashi, M. Inotsume, M. Tsuchiya, and Y. Tamura. 2004. Evaluation of the bacterial endotoxin test for quantification of endotoxin contamination of porcine vaccines. Biologicals 32: 88-93.
19. Okazaki, T., S. Sakon, T. Sasazuki, H. Sakurai, T. Doi, H. Yagita, K. Okumura, and H. Nakano. 2003. Phosphorylation of serine 276 is essential for p65 NF-κB subunit-dependent cellular responses. Biochem. Biophys. Res. Commun. 300: 807-812.
20. Dimmeler, S., A. Aicher, M. Vasa, C. Mildner-Rihm, K. Adler, M. Tiemann, H. Rutten, S. Fichtischerer, H. Martin, and A. M. Zeiher. 2001. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 108: 391-397.
21. Weidner, N., J. P. Semple, W. R. Welch, and J. Folkman. 1991. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med. 324: 1-8.
22. 2-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res. 62: 506-511.
23. Kawakami, K., M. Kawakami, and R. K. Puri. 2004. Nitric oxide accelerates interleukin-13 cytotoxin-mediated regression in head and neck cancer animal model. Clin. Cancer Res. 10: 5264-5270.
24. Goldmann, O., M. Rohde, G. S. Chhatwal, and E. Medina. 2004. Role of macrophages in host resistance to group A streptococci. Infect. Immun. 72: 2956-2963.
25. Van Lent, P. L., A. Blom, A. E. Holthuysen, C. W. Jacobs, L. B. Van De Putte, and W. B. Van Den Berg. 1997. Monocytes/macrophages rather than PMN are involved in early cartilage degradation in canonic immune complex arthritis in mice. J. Leukocyte. Biol. 61: 267-278.
26. Takeda, K., N. Yamaguchi, H. Akiba, Y. Kojima, Y. Hayakawa, J. E. Tanner, T. J. Sayers, N. Seki, K. Okumura, H. Yagita, et al. 2004. Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy. J. Exp. Med. 199: 437-448.
27. Kanda, A., S. Ebihara, H. Takahashi, and H. Sasaki. 2003. Loxoprofen sodium suppresses mouse tumor growth by inhibiting vascular endothelial growth factor. Acta Oncol. 42: 62-70.
28. Sakon, S., X. Xue, M. Takekawa, T. Sasazuki, T. Okazaki, Y. Kojima, J. H. Piao, H. Yagita, K. Okumura, T. Doi, et al. 2003. NF-κB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 22: 3898-3909.
29. Kalka, C., H. Masuda, T. Takahashi, R. Gordon, O. Tepper, E. Gravereaux, A. Pieczek, H. Iwaguro, S. I. Hayashi, J. M. Isner, et al. 2000. Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ. Res. 86: 1198-1202.
30. Vasa, M., S. Fichtischerer, A. Aicher, K. Adler, C. Urbich, H. Martin, A. M. Zeiher, and S. Dimmeler. 2001. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89: E1-E7.
31. Rafli, S., and D. Lyden. 2003. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9: 702-712.
32. Strawn, L. M., G. McMahon, H. App, R. Schreck, W. R. Kuchler, M. P. Longhi, T. H. Hui, C. Tang, A. Levitzki, A. Gazit, et al. 1996. Flk-1 as a target for tumor growth inhibition. Cancer Res. 56: 3540-3545.
33. Eubank, T. D., M. Galloway, C. M. Montague, W. J. Waldman, and C. B. Marsh. 2003. M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. J. Immunol. 171: 2637-2643.
34. Germani, A., A. Di Carlo, A. Mangoni, S. Straino, C. Giacinti, P. Turrini, P. Biglioli, and M. C. Capogrossi. 2003. Vascular endothelial growth factor modulates skeletal myoblast function. Am. J. Pathol. 163: 1417-1428.
35. Kelley, T. W., M. M. Graham, A. I. Doseff, R. W. Pomerantz, S. M. Lau, M. C. Ostrowski, T. F. Franke, and C. B. Marsh. 1999. Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B. J. Biol. Chem. 274: 26393-26398.
36. Takahashi, A., Y. Kureishi, J. Yang, Z. Luo, K. Guo, D. Mukhopadhyay, Y. Ivashchenko, D. Branellec, and K. Walsh. 2002. Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. Mol. Cell. Biol. 22: 4803-4814.
37. Skinner, H. D., J. Z. Zheng, J. Fang, F. Agani, and B. H. Jiang. 2004. Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1α, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling. J. Biol. Chem. 279: 45643-45651.
38. Zhao, Y., D. Glesne, and E. Huberman. 2003. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc. Natl. Acad. Sci. USA 100: 2426-2431.
39. Rehman, J., J. Li, C. M. Orschell, and K. L. March. 2003. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169.
40. Sapi, E., and B. M. Kacinski. 1999. The role of CSF-1 in normal and neoplastic breast physiology. Proc. Soc. Exp. Biol. Med. 220: 1-8.
41. Lin, E. Y., A. V. Nguyen, R. G. Russell, and J. W. Pollard. 2001. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193: 727-740.
42. Pei, X. H., Y. Nakanishi, K. Takayama, F. Bai, and N. Kara. 1999. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Br. J. Cancer 79: 40-46.